UNICOIN

UNICOIN

TBA
21,722 Views
UNICOIN’s objective is to create the world’s first art-tech cryptocurrency. In the spirit of Satoshi Nakamoto, it will serve as an eye-opener that cryptocurrencies are a true alternative to the irrational foundations of the offline-markets. UNICOIN is driven by the idea of demonstrating in real-time that digital currencies are more sustainable than state currencies if only backed by a sufficiently large number of users. We are currently in friendly user test and our token pre-sale will start 9th October 2017.
4.5
TOTAL SCORE
4.2
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Dates: TBA
Token info
Ticker: UCN
Platform: Ethereum
Financial
ICO Price: 1 UCN = 0.0035 USD
Accepting: ETH
Hard cap: 30000000 USD
2016
Project analysis
2016-2017
Coding
2017
User Feedback
2017-10-09
Pre-sale
2017-11-01
Launch
2018
100,000,000 Distribution
Screenshots taken on 5 Feb 2018
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
ReverseDAO
ReverseDAO is a solution to all of the problems above; it is a platform that connects the Metaverse with real-world assets. Fiat and economic units that are bound with world assets can now be represented, stored, and transferred onto the blockchain just as easily as cryptocurrencies.
Upcoming
Artcoin
The art world is traditionally anything but transparent, and that’s where ArtCoin, an investor-driven collective, creates real change for investors. Guiding users through transactions using cryptocurrencies, ArtCoin enables investors to benefit from the increased security and transparency of the Smart Contracts platforms. By pulling together information that everyday investors normally can’t access, ArtCoin democratizes the art market and acts as a direct liaison between investors and the art industry.
Upcoming
Orion Protocol
ORION is a new kind of blockchain investment platform that combines the best features of exchanges, brokerages, and instant trading apps. The platform is built around a liquidity aggregator connected to all of the major crypto exchanges, as well as its own internal decentralized exchange, enabling users to gain the best price for their trades from a single portal. Along with powerful tools for portfolio management, ORION offers exceptional security, convenience, and flexibility. The platform is suitable for experienced traders, institutional investors, and newcomers alike.
Upcoming
Elements Estates
"Elements Estates is creating a Blockchain-based platform with underlying unique portfolio of real estate deriving from banks’ distressed assets. The platform will offer the ability to utilize ELES tokens through purchase or rent of real estate and other services, all primarily related to newly developed and modern properties in platform ownership. Elements Estates is giving you the opportunity to get involved in something that will enable growth of token value from unlocking the hidden value of the distressed assets deriving from non-performing bank portfolios, usually reserved for major players."
Upcoming
REDi
A blockchain-based integrative data marketplace for the global renewable energy industry. The REDi Infranet will empower various renewable energy producers, consumers, and industry experts to consolidate, verify, and distribute data in the search for improved productivity and efficiency towards true sustainability.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.